Reports Q4 revenue $40.52M, consensus $40M. The company said, "Enfusion ended 2022 – its first full calendar year after the IPO – on a high note. During volatile market conditions, the resiliency of our business tends to shine and accentuate the value we provide to our clients. Investment managers have been reimagining their technology infrastructure without a clear solution. Many have selected Enfusion’s software and services as a strategic solution to transform their legacy systems with our robust, contiguous cloud native end to end software platform."
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on ENFN:
